US Fed rate cut: Nuvama cautions investors – past cuts did not lead to immediate equity boosts

Nuvama warns of market caution as the US Fed considers rate cuts, highlighting historical complexities where past cuts did not lead to immediate equity boosts. The firm advises reducing exposure to expensive cyclicals and focusing on resilient sectors like defensives and private banks.

Pranati Deva
Published13 Sep 2024, 11:22 AM IST
Trade Now
Equities and rate cuts: Theory vs History. Nuvama warns of caution as markets enter Fed rate cut phase
Equities and rate cuts: Theory vs History. Nuvama warns of caution as markets enter Fed rate cut phase

In a recent note, brokerage house Nuvama emphasised that markets are entering a new phase as the US Federal Reserve (Fed) prepares for potential rate cuts. While theory suggests that lower rates boost equity valuations, historical evidence paints a more complex picture. Past rate cuts, in 2001, 2007–08, and 2019, saw varied market responses, and Nuvama believes similar caution is warranted this time around as well.

Historical Data: Rate Cuts and Market Movements

According to Nuvama, past cycles of Fed rate cuts have rarely led to an immediate re-rating of equities. In 2001, the Nifty fell by 35 percent after the rate cuts, despite expectations of a boost. The situation in 2007 saw an initial surge in the Nifty, only to crash by 60 percent the following year, while in 2019, rate cuts did not result in a significant market re-rating, and the Nifty remained largely flat, noted the brokerage.

These outcomes are because rate cuts generally follow periods of earnings slowdowns. Even though they reduce the cost of capital, earnings downgrades and weak growth expectations can neutralise these advantages. Nuvama asserted that only deep rate cuts, coupled with low valuations, have historically been effective in supporting equity markets.

Also Read | Markets will be driven by more bottom-up stock ideation, says ASK Investment

Key Variables: US Labor Market, Domestic Demand, and Valuations

Nuvama identified three key factors that influence market reactions during Fed rate cuts: the state of the US labour market, domestic demand, and market valuations. 

Today, many US labour indicators suggest recession risks, while domestic demand is weak and valuations are elevated. In contrast, in 2007, booming domestic demand helped markets rally before the global financial crisis led to a massive sell-off in 2008.

Nuvama observed that the US bond market was showing signs of a potential recession, with the yield curve disinvesting after two years. In 2019, the Fed's pre-emptive rate cuts helped avoid a recession, but moderating commodity prices, such as steel and oil, now suggested global demand challenges.

The report questioned whether domestic growth could counterbalance this global backdrop. In 2007, a strong domestic economy fueled a rally in Indian equities, but current demand indicators, like nominal GDP growth, were in single digits, similar to 2001 and 2019. Nuvama doubts the same domestic strength would prevail, especially with slowing earnings and weaker demand across emerging markets.

Also Read | B&K recommends a sector-neutral strategy, lists top picks and portfolio changes

Valuations were also stretched, similar to 2007, with most sectors, except banks, trading at more than two standard deviations above their 10-year averages. While recent market performance had been strong, particularly in midcaps, Nuvama noted that the fundamentals of Indian companies—marked by solid free cash flows and non-leveraged balance sheets—could soften the impact of any cyclical downturn.

Expensive Cyclicals: A Warning from History

Nuvama drew parallels between today’s cyclicals—industrials, PSUs, autos, and metals—and IT stocks in 2001, which suffered the most after an initial surge. Similarly, cyclicals were hit hard in 2008. Given their significant outperformance over the past 18 months, cyclicals are now seen as vulnerable to a correction.

The brokerage recommended reducing exposure to these sectors, as their valuations have become more than two standard deviations expensive. The risks are exacerbated by weak domestic demand and global recessionary trends, particularly in the US.

Also Read | Bernstein’s 10-stock India model portfolio got an update. Here’s the lowdown.

Defensive Bias: Where to Invest Now

In contrast to cyclicals, Nuvama advised positioning portfolios with a strong bias towards defensives such as cash cows, insurance, telecoms, pharma, and consumer sectors. These sectors have shown resilience during previous market downturns and are well-positioned to outperform in a volatile environment. The report also emphasised the importance of private banks, which have underperformed in recent times but are expected to catch up due to improving earnings and attractive valuations.

Nuvama noted that defensive sectors have already begun outperforming cyclicals, particularly post-elections, and believes this trend will continue. The firm's model portfolio has benefited from an overweight position in defensives, delivering a 5 percent alpha over the past three months and the past year.

Private Banks: A Key Opportunity

Despite potential near-term pressure from rate cuts, Nuvama is bullish on private banks, which are seen as the only cyclical sector worth holding. Although private banks have underperformed, their valuations are now at a significant discount, and their earnings outlook is improving. The sector has historically fared well during periods of credit growth slowdown and rate cuts.

Also Read | Portfolio reshuffle: Private banks, consumption stocks find favour with funds

Nuvama also reiterated that delayed rate cuts have often hurt expensive pockets of the market, such as Nasdaq and Indian IT in 2001 and cyclicals in 2008. Today, cyclicals and midcaps are similarly exposed, making defensive sectors and private banks the safer bet in this phase of the cycle.

In summary, Nuvama advised caution as markets transition into a new phase driven by Fed rate cuts. The report emphasised the need for a defensive portfolio, with reduced exposure to expensive cyclicals and a focus on sectors that have proven resilient in past downturns. While rate cuts may provide some relief, the brokerage believes valuations are too stretched to expect a significant market re-rating, and defensive positioning remains the best strategy for the current environment.

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before taking any investment decisions.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:13 Sep 2024, 11:22 AM IST
Business NewsMarketsStock MarketsUS Fed rate cut: Nuvama cautions investors – past cuts did not lead to immediate equity boosts

Most Active Stocks

Tata Steel share price

155.25
03:58 PM | 16 OCT 2024
-0.4 (-0.26%)

Tata Power share price

460.35
03:58 PM | 16 OCT 2024
-3.15 (-0.68%)

Bharat Petroleum Corporation share price

350.85
03:57 PM | 16 OCT 2024
1.65 (0.47%)

Bharat Electronics share price

285.65
03:49 PM | 16 OCT 2024
-3.15 (-1.09%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Coforge share price

7,120.75
10:51 AM | 7 OCT 2024
-2.4 (-0.03%)

Vijaya Diagnostic Centre share price

984.80
10:51 AM | 7 OCT 2024
-4.15 (-0.42%)

Dr. Lal Pathlabs share price

3,408.00
10:50 AM | 7 OCT 2024
-86.25 (-2.47%)
More from 52 Week High

Bombay Burmah Trading Corporation share price

2,519.95
10:51 AM | 7 OCT 2024
-245.3 (-8.87%)

Jubilant Ingrevia share price

728.55
10:51 AM | 7 OCT 2024
-65.7 (-8.27%)

Triveni Engineering & Indus share price

426.65
10:51 AM | 7 OCT 2024
-35.75 (-7.73%)

Vodafone Idea share price

9.08
10:51 AM | 7 OCT 2024
-0.72 (-7.35%)
More from Top Losers

Astrazeneca Pharma India share price

7,832.35
10:51 AM | 7 OCT 2024
399.85 (5.38%)

Finolex Industries share price

280.85
10:51 AM | 7 OCT 2024
9.2 (3.39%)

Macrotech Developers share price

1,206.20
10:51 AM | 7 OCT 2024
34.35 (2.93%)

JK Lakshmi Cement share price

797.60
10:51 AM | 7 OCT 2024
17.2 (2.2%)
More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      77,405.00-220.00
      Chennai
      77,411.00-220.00
      Delhi
      77,563.00-220.00
      Kolkata
      77,415.00-220.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00

      Popular in Markets

        HomeMarketsPremiumInstant LoanMint Shorts